Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Conjugates of monocyclic β-lactams and siderophore mimetics : a patent evaluation (WO2023023393)
ID
Krajnc, Alen
(
Author
),
ID
Gobec, Stanislav
(
Author
)
PDF - Presentation file,
Download
(3,28 MB)
MD5: E07AC01825155A294E92CE4A687D2BAF
URL - Source URL, Visit
https://www.tandfonline.com/doi/full/10.1080/13543776.2023.2262135
Image galllery
Abstract
Introduction: β-Lactams, which include monobactams, remain the most important class of antibiotics worldwide. Aztreonam, the only monobactam in clinical use, has remarkable activity against many Gram-negative bacteria, but limited activity against some of the most problematic multidrug-resistant (MDR) pathogens, such as MDR Pseudomonas aeruginosa and Acinetobacter baumannii co-expressing extended-spectrum- and metallo-β-lactamases, which can inactivate aztreonam by hydrolysis. Areas covered: Structurally novel siderophore-conjugated aztreonam derivatives with improved antibacterial properties against several high-priority pathogens are claimed. This invention reports that sidechain extension of aztreonam is tolerated; the coupling of its aminothiazoloxime carboxylic acid part with a siderophore mimetic significantly improved the antibacterial activity against several problematic strains, including MDR A. baumannii isolates with carbapenemase/cephalosporinase activity. Expert Opinion: Finding new strategies to tackle bacterial resistance to β-lactam antibiotics is critical. Considering that β lactams are validated and safe drugs, this research may stimulate the field to develop new ideas in the arena of antimicrobial drug discovery, particularly with respect to siderophore mimetics.
Language:
English
Keywords:
antimicrobial resistance
,
conjugates
,
aztreonam
,
anticoagulant
,
β-lactams
,
monocyclic β-lactams
,
siderophores
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2023
Number of pages:
Str. 471-476
Numbering:
Vol. 33, no. 7-8
PID:
20.500.12556/RUL-152245
UDC:
615.015.8
ISSN on article:
1354-3776
DOI:
10.1080/13543776.2023.2262135
COBISS.SI-ID:
171047171
Publication date in RUL:
14.11.2023
Views:
545
Downloads:
48
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Expert opinion on therapeutic patents
Shortened title:
Expert opin. ther. pat.
Publisher:
Taylor & Francis
ISSN:
1354-3776
COBISS.SI-ID:
15313959
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Secondary language
Language:
Slovenian
Keywords:
protimikrobna odpornost
,
aztreonam
,
konjugati
,
β-laktami
,
monociklični β-laktami
,
siderofori
,
bakterijska rezistenca
,
farmacevtska kemija
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Project number:
N1-0169
Name:
Kovalentni pristop k boju proti bakterijski rezistenci
Funder:
ARRS - Slovenian Research Agency
Project number:
Z1-4405
Name:
Razvoj novih antibiotikov s sočasnim zaviranjem beta-laktamaz in penicilin-vezočih proteinov
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back